Pentamidine inhalation as a prophylaxis against Pneumocystis carinii pneumonia after therapy of acute renal allograft rejection with orthoclone (OKT3).
Spieker
C
C
Medizinische Poliklinik, Westfälischen Wilhelms-Universität, Münster, Germany.
Barenbrock
M
M
Tepel
M
M
Buchholz
B
B
Rahn
K H
KH
Zidek
W
W
D000280:Administration, Inhalation; D000293:Adolescent; D000328:Adult; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D006084:Graft Rejection / Q000276:immunology*; D006801:Humans; D007108:Immune Tolerance / Q000187:drug effects / Q000276:immunology; D016030:Kidney Transplantation / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D016853:Muromonab-CD3 / Q000008:administration & dosage / Q000009:adverse effects*; D009894:Opportunistic Infections / Q000276:immunology / Q000517:prevention & control*; D010419:Pentamidine / Q000008:administration & dosage*; D011020:Pneumonia, Pneumocystis / Q000276:immunology / Q000517:prevention & control*; D011183:Postoperative Complications / Q000276:immunology*; D012307:Risk Factors
D016853:Muromonab-CD3; D010419:Pentamidine